BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 34941697)

  • 1. Isolation and Characterization of A2-EPTX-Nsm1a, a Secretory Phospholipase A
    Abdullah NAH; Rusmili MRA; Zainal Abidin SA; Shaikh MF; Hodgson WC; Othman I
    Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effect of phospholipase A
    Abdullah NAH; Sainik NQAV; Esa E; Muhamad Hendri NA; Ahmad Rusmili MR; Hodgson WC; Shaikh MF; Othman I
    Front Pharmacol; 2022; 13():935418. PubMed ID: 36313292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative characterization of two toxic phospholipases A2 from Indian cobra (Naja naja naja) venom.
    Basavarajappa BS; Gowda TV
    Toxicon; 1992 Oct; 30(10):1227-38. PubMed ID: 1279838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equatorial Spitting Cobra (
    Tan CH; Tan KY; Wong KY; Tan NH; Chong HP
    Toxins (Basel); 2022 Jul; 14(8):. PubMed ID: 36006183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic characterization of venom of the medically important Southeast Asian Naja sumatrana (Equatorial spitting cobra).
    Yap MK; Fung SY; Tan KY; Tan NH
    Acta Trop; 2014 May; 133():15-25. PubMed ID: 24508616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical cross-reactivity of neurotoxic phospholipase A2 enzymes from Indian cobra (Naja naja naja) venom using polyclonal antibodies.
    Basavarajappa BS; Guru SC; Gowda TV
    Toxicon; 1993 Sep; 31(9):1167-77. PubMed ID: 7505490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of a neurotoxic phospholipase A2 from Indian cobra (Naja naja naja) venom.
    Bhat MK; Prasad BN; Gowda TV
    Toxicon; 1991; 29(11):1345-9. PubMed ID: 1814010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Diversity and Novelty of Toxin Genes in
    Chong HP; Tan KY; Tan NH; Tan CH
    Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30754700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant Activity of
    Kazandjian TD; Arrahman A; Still KBM; Somsen GW; Vonk FJ; Casewell NR; Wilkinson MC; Kool J
    Toxins (Basel); 2021 Apr; 13(5):. PubMed ID: 33922825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of Naja sumatrana (equatorial spitting cobra) venom and its major toxins in experimentally envenomed rabbits.
    Yap MK; Tan NH; Sim SM; Fung SY; Tan CH
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2890. PubMed ID: 24901441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive Distribution of Secretory Phospholipases A₂ in the Venoms of Afro-Asian Cobras (Subgenus:
    Tan CH; Wong KY; Tan NH; Ng TS; Tan KY
    Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30769779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of an endogenous inhibitor of phospholipase A2 from Indian cobra (Naja naja naja) venom.
    Rudrammaji LM; Gowda TV
    Toxicon; 1998 Apr; 36(4):639-44. PubMed ID: 9643477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and pharmacological characterization of α-Elapitoxin-Na1a, a novel short-chain postsynaptic neurotoxin from the venom of the Chinese Cobra (Naja atra).
    Liang Q; Huynh TM; Isbister GK; Hodgson WC
    Biochem Pharmacol; 2020 Nov; 181():114059. PubMed ID: 32473162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and activation of phospholipase A2 isoforms from Naja mossambica mossambica (spitting cobra) venom.
    Ahmad T; Lawrence AJ
    Toxicon; 1993 Oct; 31(10):1279-91. PubMed ID: 8303722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the venom proteomes and potential therapeutics of 3 African naja subgenera.
    Offor BC; Piater LA
    Toxicon; 2024 Jul; 245():107792. PubMed ID: 38838860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of a myotoxic phospholipase A2 from Indian cobra (Naja naja naja) venom.
    Bhat MK; Gowda TV
    Toxicon; 1989; 27(8):861-73. PubMed ID: 2781585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative venomics and preclinical efficacy evaluation of a monospecific Hemachatus antivenom towards sub-Saharan Africa cobra venoms.
    Sánchez A; Segura Á; Pla D; Munuera J; Villalta M; Quesada-Bernat S; Chavarría D; Herrera M; Gutiérrez JM; León G; Calvete JJ; Vargas M
    J Proteomics; 2021 May; 240():104196. PubMed ID: 33775842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human scFv antibody fragments against phospholipase A2 from Naja naja and Echis carinatus snake venoms: In vivo neutralization and mechanistic insights.
    Kumar A; Madni ZK; Chaturvedi S; Salunke DM
    Mol Immunol; 2024 Jan; 165():55-67. PubMed ID: 38154407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the hemolysis of human erythrocytes by cardiotoxins from Naja naja kaouthia and Naja naja atra venoms and a phospholipase A2 with cardiotoxin-like activities from Bungarus fasciatus venom.
    Jiang MS; Fletcher JE; Smith LA
    Toxicon; 1989; 27(2):247-57. PubMed ID: 2718193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Neurotoxic Snake Venom without Phospholipase A
    Wong KY; Tan KY; Tan NH; Tan CH
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33466660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.